JAM
TEVA icon

Jolley Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Jolley Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,568
Closed -$318K – 183
2017
Q2 		$318K Sell
9,568
-13,950
-59% -$432K 0.22% 55
2017
Q1 		$755K Buy
23,518
+13,640
+138% +$465K 0.54% 38
2016
Q4 		$358K Sell
9,878
-100
-1% -$3.99K 0.26% 48
2016
Q3 		$459K Buy
9,978
+500
+5% +$26.1K 0.37% 40
2016
Q2 		$476K Buy
9,478
+1,550
+20% +$82.5K 0.38% 42
2016
Q1 		$424K Buy
7,928
+900
+13% +$52.8K 0.39% 39
2015
Q4 		$461K Sell
7,028
-802
-10% -$49.6K 0.44% 41
2015
Q3 		$442K Hold
7,830
– – 0.45% 40
2015
Q2 		$463K Sell
7,830
-40
-0.5% -$2.47K 0.42% 42
2015
Q1 		$490K Sell
7,870
-100
-1% -$5.81K 0.41% 44
2014
Q4 		$458K Sell
7,970
-535
-6% -$29.8K 0.38% 45
2014
Q3 		$457K Sell
8,505
-30
-0.4% -$1.59K 0.37% 45
2014
Q2 		$447K Sell
8,535
-6,820
-44% -$349K 0.33% 53
2014
Q1 		$811K Buy
15,355
+10,000
+187% +$462K 0.6% 40
2013
Q4 		$215K Sell
5,355
-9,000
-63% -$354K 0.17% 54
2013
Q3 		$542K Sell
14,355
-11,850
-45% -$462K 0.45% 45
2013
Q2 		$1.03M Buy
+26,205
New +$1.02M 0.83% 34

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jolley Asset Management's TEVA Position: Q3 2017 in Review

Jolley Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 9,568 shares — an estimated $318K sold.

Jolley Asset Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $1.03M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Jolley Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Jolley Asset Management sold 9,568 Teva Pharmaceuticals shares in Q3 2017, an estimated $318K.
  • Jolley Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Jolley Asset Management's Teva Pharmaceuticals position peaked at $1.03M in Q2 2013.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Jolley Asset Management's 13F filing for Q3 2017, filed 12 Oct 2017.